Tue Oct 4, 2022 – 8:44 pm EDT
This article was originally published by The Defender – Children’s Health Defense’s News & Views Website
(Children’s Health Defense) – The National Institutes of Health (NIH) funded a malaria vaccine trial study that used genetically modified (GM) mosquitoes to vaccinate humans.
A team of researchers at the University of Washington conducted the study, which was published in the Science Translational Medicine journal.
The study involved 26 participants who received three to five “jabs” — or bites from a small box containing 200 GM mosquitoes — over a 30-day period.
Sanaria, a company funded in part by the Bill & Melinda Gates Foundation (BMGF), is closely connected to the research, and the researchers involved in the trial use a gene-editing technology heavily promoted by Bill Gates.
Genetically modified mosquitoes used as ‘flying syringes’
The trial used malaria-causing Plasmodium mosquitoes that were genetically modified to avoid causing sickness in humans to infect participants with a “minor” version of malaria — insufficient to cause severe illness, but enough to make the humans create antibodies.
Dr. Sean Murphy, lead author of the study, told NPR, “We use the mosquitoes like they’re 1,000 small flying
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors
